Implanet reports completion of the first idiopathic scoliosis surgical procedure to use the JAZZ platform in Brazil.
This follows closely the ANVISA approval for JAZZ in mid-4Q15.
Source: Implanet
Brazil accounts for 83% of a Latin American vertebral fusion market that Implanet has valued at €139MM (~$152MM). Company leadership estimates that ~27,000 vertebral fusion procedures occurred in the Brazil market, during 2015.
Implanet reports completion of the first idiopathic scoliosis surgical procedure to use the JAZZ platform in Brazil.
This follows closely the ANVISA approval for JAZZ in mid-4Q15.
Source: Implanet
Brazil accounts for 83% of a Latin American vertebral fusion market that Implanet has...
Implanet reports completion of the first idiopathic scoliosis surgical procedure to use the JAZZ platform in Brazil.
This follows closely the ANVISA approval for JAZZ in mid-4Q15.
Source: Implanet
Brazil accounts for 83% of a Latin American vertebral fusion market that Implanet has valued at €139MM (~$152MM). Company leadership estimates that ~27,000 vertebral fusion procedures occurred in the Brazil market, during 2015.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.